Congratulations to Dr. Andrey Ivanov for his recent R21 award titled, "Predicting actionable cancer vulnerabilities enabled by mutant-directed protein-protein interactions”.
With this award, Dr. Ivanov becomes a member and will represent Emory University at the Informatics Technology for Cancer Research (ITCR) Program of the NIH National Cancer Institute. ITCR is a trans-NCI program supporting investigator-initiated, research-driven informatics technology development spanning all aspects of cancer research.